Secondary syphilis, the hematogenous spread of Treponema pallidum, usually occurs 4-10 weeks after initial exposure. The skin is involved in 70% of cases, with maculopapular, vesiculobullous, and ulcerative morphologies possible at presentation, making the diagnosis of secondary syphilis challenging given its ability to mimic many other conditions. We present an atypical case of secondary syphilis that closely resembled erythema multiforme (EM) clinically and histologically

The literature demonstrates practice gaps in performance of the genital skin examination. To further elucidate and understand these practice gaps, we surveyed dermatologist and obstetrician-gynecologist (OB/GYN) attending and resident physicians. Analysis of 73 dermatology survey responses revealed a lack of satisfaction with training received in examination of the female genitalia. Moreover, examination of 69 OB/GYN survey responses showed a lack of satisfaction with residency training received to identify high risk skin lesions. Interestingly, only 52.2% of OB/GYN respondents inspect perianal skin during pelvic region examinations. Our results highlight the need to improve residency training through standardization of breast/genitalia skin examinations during both dermatology and OB/GYN residency and for increased collaboration between specialties.

In recent months, the general public has become more cognizant of the potential of oral minoxidil to promote hair growth; this was promulgated, in part, by an article published in the New York Times entitled, "An Old Medicine Grows New Hair for Pennies a Day, Doctors Say." Minoxidil was added to the pharmacologic armamentarium as an antihypertensive nearly 60 years ago and was found to trigger hypertrichosis in many patients, but its use dropped sharply as cardiologists observed a number of adverse cardiovascular events including ischemic heart disease, left ventricular hypertrophy, pleural effusions, and pericardial effusions. Studies in the realm of dermatology have explored the utility and safety of low dose oral minoxidil (LDOM) for management of alopecia. This article highlights potential clinical conundrums posed by these rare but severe cardiovascular complications and the importance of collaboration between cardiologists and dermatologists when employing this agent in patients with cardiorenal or cardiovascular risk factors.